scispace - formally typeset
J

John M. Leedom

Researcher at University of Southern California

Publications -  85
Citations -  7241

John M. Leedom is an academic researcher from University of Southern California. The author has contributed to research in topics: Meningitis & Ampicillin. The author has an hindex of 35, co-authored 85 publications receiving 7167 citations. Previous affiliations of John M. Leedom include University of California, San Diego & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

TL;DR: It is demonstrated that AZT administration can decrease mortality and the frequency of opportunistic infections in a selected group of subjects with AIDS or AIDS-related complex, at least over the 8 to 24 weeks of observation in this study.
Journal ArticleDOI

Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

TL;DR: This multicenter, randomized trial was AIDS (acquired immunodeficiency syndrome) and tested whether this triple combination would improve immunologic and virologic effects in vivo by comparing it with a combination of zidovudine and didanosine in a 48-week phase II, randomized clinical trial in adults with HIV-1 disease who had previously received prolonged nucleoside therapy.
Journal ArticleDOI

Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus.

TL;DR: The CMV PCR was more sensitive than the standard culture assay, can be completed in one to two days, uses only 20 microL of blood, and may be useful for rapidly detecting CMV in clinical specimens.
Journal ArticleDOI

Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection.

TL;DR: Delayed therapy of tuberculosis in HIV-infected patients with culture-proven tuberculosis seen at a 1,900-bed general hospital serving a predominantly indigent population in Los Angeles was common and was not due to atypical manifestations of tuberculosis.